Interactions between Shiga toxins and human polymorphonuclear leukocytes
- 14 July 2008
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 84 (4) , 1019-1027
Abstract
Human intestinal infections by Shiga toxin (Stx)-producing Escherichia coli cause hemorrhagic colitis and hemolytic uremic syndrome (HUS), which represents the main cause of acute renal failure in early childhood. In HUS, Stx released in the gut enter the bloodstream and are targeted to renal endothelium. The mechanism of toxin delivery is still a matter of debate, although the role of polymorphonuclear leukocytes (PMN) as a Stx carrier has been indicated. The aim of this paper was to better define the interactions between Stx and human PMN. Direct and indirect flow cytometric analysis and binding experiments with radiolabeled toxins demonstrated that Stx bind to the surface of human mature PMN but not to immature PMN from G-CSF-treated donors. The use of the human myeloid leukemia cell (HL-60) model for inducible cell differentiation confirmed that the toxin binding occurs only after granulocytic differentiation. Stx binding caused a delay of the spontaneous apoptosis of PMN, as shown by the delayed appearance of apoptotic nuclei and activation of caspase 3 and by the higher number of cells negative to the annexin V-binding assay after 48 h. Moreover, flow cytometric analysis of mixed Stx-positive and Stx-negative PMN populations showed that the toxins were transferred from positive to negative PMN. The delayed, spontaneous apoptosis and the passage of the toxic ligand from older PMN to new, mature cells entering the circulation from the bone marrow may explain the previously reported persistence of Stx in the blood of children with HUS.Keywords
Funding Information
- University of Bologna
- Italian Ministry of Health (N98, CCM 2004)
- European Community Network of Excellence Med-Vet-Net (FOOD-CT-2004-506122)
This publication has 46 references indexed in Scilit:
- Molecular Damage and Induction of Proinflammatory Cytokines in Human Endothelial Cells Exposed to Shiga Toxin 1, Shiga Toxin 2, and α-SarcinInfection and Immunity, 2007
- Comparative Analysis of the Abilities of Shiga Toxins 1 and 2 To Bind to and Influence Neutrophil ApoptosisInfection and Immunity, 2007
- Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytesNephrology Dialysis Transplantation, 2007
- Shiga Toxins Present in the Gut and in the Polymorphonuclear Leukocytes Circulating in the Blood of Children with Hemolytic-Uremic SyndromeJournal of Clinical Microbiology, 2006
- Serum Amyloid P Component Binding to Shiga Toxin 2 Requires Both A Subunit and B PentamerInfection and Immunity, 2003
- Glycosphingolipid patterns in human promyelocytic HL-60 leukemia cells susceptible or resistant to differentiation induction by phorbol 12-myristate 13-acetateBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- The Colonic Pathology of Escherichia coli 0157American Journal of Surgical Pathology, 1990
- Purification of Shiga toxin by α‐d‐galactose‐(1 → 4)‐β‐d‐galactose‐(1 → 4)‐ β‐d‐glucose‐(1 →) receptor ligand‐based chromatographyFEBS Letters, 1989
- Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomesEuropean Journal of Biochemistry, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976